La Vanguardia published a press release: 'The future of biotechnology: lower-cost treatments in a short period of time'

by Som Biotech

SOM Bio​tech has designed a computational Artificial Intelligence-based method to analyze molecular structures and select the best option after performing more than 2.5 million comparisons in each p...

Read more

La Marató awards funding to a rare diseases project at IRB Barcelona

by IRB Barcelona - Instituto de Investigación Biomédica

The collaborative project will focus on identifying the cellular defects that lead to Cohen Syndrome. Awarded €400,000 of funding, the project will last for 3 years. The Microtubule Organizati...

Read more

SOM Biotech continues working during coronavirus outbreak to bring therapies for patients with rare diseases

by Som Biotech

While the coronavirus o​utbreak grows worldwide, at SOM Biotech we continue working on our pipeline to bring therapies for patients with rare diseases.

Read more

Minoryx Therapeutics appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of its Belgian subsidiary

by Minoryx Therapeutics

Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that it has appointed Didier Le Normand as Group CFO as well as General Manager of its...

Read more

The Barcelona Macula Foundation participates in World Rare Disease Day and continues researching into Stargardt’s disease and Retinitis Pigmentosa

by BMF Barcelona Macula Foundation: Research for Vision

​For another year, the Barcelona Macula Foundation (BMF) is participating in World Rare Disease Day, whose main aim is to sensitise, educate and inform the public about these pathologies and positio...

Read more

SOM Biotech announces a worldwide license with Corino Therapeutics for its SOM0226 compound against amyloidosis

by Som Biotech

SOM Biotech, a leading clinical-stage biopharmaceutical company specialized in drug repurposing to treat rare diseases with a focus on CNS diseases today announces an exclusive worldwide license agree...

Read more

Researchers find a gene that causes Opitz C syndrome in the only patient with this rare disorder in Catalonia

by Universitat de Barcelona

In the new study, the experts described for the first time, the existence of a novo mutation –p.Q638*- located in the gene MAGEL2 of the only diagnosed person with Opitz C syndrome in Catalonia. Ide...

Read more

Ramón Areces Foundation, new UB researchers on rare diseases, tumor progression and cellular stress

by Universitat de Barcelona

Research projects led by UB researchers Francesc Palau Martínez, Marçal Pastor-Anglada and Antonio Zorzano Olarte will receive financial support from the Ramón Areces Foundation, in the eighteenth ...

Read more

New drug discovery company in the area of rare diseases

by CIC bioGUNE

The new company, Atlas Molecular Pharma, aims to develop a technology capable of detecting molecules which stabilize proteins involved in the development of certain rare diseases. The venture capital ...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream